Hironori Sakai
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 25, 2023
Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines.Naoto Yoshino, Takuya Yokoyama, Hironori Sakai
|Nov 11, 2022
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients.Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi
|Jun 24, 2022
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination.Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji
|Apr 23, 2022
Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine.Mohammad Said Ashenagar, Akiko Matsumoto, Hironori Sakai
|Feb 26, 2022
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi
Pageof 1
Frequent Collaborators
3 joint publications
Kimikazu Yakushijin
3 joint publications
Yasuyuki Saito
3 joint publications
Hironobu Minami
2 joint publications
Katsuya Yamamoto
2 joint publications
Mitsuhiro Ito
1 joint publications
Mohammad Said Ashenagar
1 joint publications
Akiko Matsumoto
1 joint publications
Mikiko Tokiya
1 joint publications
Megumi Hara
1 joint publications
Taiji Koyama
